Products

FibriCheck
Qompium nv
Cardiology AI
FibriCheck is a medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.

See all 1 product →

About Qompium nv

Qompium nv is a pioneering Belgian digital health company primarily focused on advancing cardiac care through innovative AI-powered mobile health solutions. The company’s flagship product, FibriCheck, is a medically certified smartphone and smartwatch application designed for the detection and monitoring of irregular heart rhythms, including atrial fibrillation (AF). FibriCheck leverages the device’s camera signal, making it the world’s first CE and FDA-approved medical smartphone application for this purpose. This technology enables physicians to facilitate remote patient monitoring, offering a convenient and accessible tool for early detection and ongoing management of cardiac arrhythmias.

FibriCheck has demonstrated significant impact, assisting over 450,000 individuals across 43 countries by performing more than 4 million heart rhythm measurements and identifying approximately 40,000 heart rhythm disorders. The application integrates with popular consumer devices, including those from partners like Samsung and Fitbit, thereby expanding its reach and utility in real-world clinical settings. By providing a user-friendly and clinically validated solution for heart rhythm assessment, Qompium aims to empower both patients and healthcare providers in the proactive management of cardiovascular health.

Focus Areas

Digital health Heart rhythm monitoring Atrial fibrillation detection Software as a Medical Device (SaMD) AI in healthcare Remote patient monitoring Cardiovascular care

Business Intelligence

Key InvestorsLRM, EIT Health
PartnershipsSamsung, Fitbit, Smart Meter, patientMpower, Inhealthcare, Amphia Hospital, Spaarne Gasthuis, Alrijne Hospital, Rode Kruis Ziekenhuis, Midwest Cardiovascular Institute, Benenden Health, Daiichi Sankyo
TechnologyFibriCheck utilizes photoplethysmographic (PPG) sensors from smartphones and smartwatches. Its core technology involves medically-certified AI algorithms and a deep neural network trained on extensive datasets to analyze heart rhythm data. The platform includes a patient-facing mobile application, an AI algorithm for analysis, and a healthcare provider portal for clinical oversight and decision support.
FDA Clearances1 (for FibriCheck ecosystem) cleared products (estimated)

What Physicians Need to Know

Digital Health Pioneer
Qompium, through its FibriCheck app, has been a pioneering force in digital health since 2014, offering a smartphone-based solution for heart rhythm monitoring.
Heart Rhythm Monitoring
Specializes in convenient and non-invasive heart rhythm monitoring using photoplethysmography (PPG) technology via smartphone cameras and smartwatches.
Atrial Fibrillation Detection
FibriCheck is a clinically validated medical device specifically designed for the timely detection and monitoring of atrial fibrillation (AF), with high sensitivity and specificity.
Software as a Medical Device (SaMD)
FibriCheck is the world's first CE and FDA-approved medical smartphone application for heart rhythm disorders using the camera signal, demonstrating robust regulatory compliance.
AI in Healthcare
Utilizes automated algorithms to analyze PPG data for heart rhythm detection, indicating the application of AI for accurate and efficient analysis of medical data.
Remote Patient Monitoring
Enables remote monitoring of patients' heart rhythms, allowing for continuous oversight and early intervention, which proved particularly valuable during the COVID-19 pandemic.
Cardiovascular Care Enhancement
Aids in comprehensive cardiovascular care by providing a tool for early detection of AF, thereby contributing to the reduction of stroke risk and improved management of heart conditions.
Physician Tip

For physicians, Qompium's FibriCheck offers a powerful, user-friendly tool for continuous and remote heart rhythm monitoring, particularly for detecting atrial fibrillation. Its CE and FDA approvals provide assurance of its medical device quality and clinical validation. The device-agnostic nature (smartphones, smartwatches) increases patient adherence and accessibility. Integrating FibriCheck into patient management can lead to earlier detection of arrhythmias, facilitate timely interventions, and potentially reduce stroke incidence, all while minimizing the need for frequent in-person visits for rhythm checks. It's important to note that FibriCheck requires a prescription for activation and use, ensuring physician oversight.

While Qompium's former business unit, Extra Horizon (a medical backend-as-a-service), has spun off, its foundational development within Qompium highlights the company's deep expertise in building secure, compliant, and scalable medical application backends. This background suggests FibriCheck is built on a robust infrastructure designed for interoperability and adherence to stringent data privacy and security standards (e.g., ISO13485, 21 CFR part 11, IEC-62304, ISO14971). FibriCheck itself is designed to integrate with various consumer devices equipped with PPG sensors, including smartwatches and smartphones, and has established partnerships with companies like Samsung and Fitbit.

Products by Qompium nv

1 product in the directory

FibriCheck
Qompium nv
Cardiology AI
FibriCheck is a medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.

What the Web Says

Qompium nv, particularly known for its product 'Cardiograph' (now 'Qompium Cardiograph'), receives generally positive reviews for its innovative approach to cardiac monitoring through smartphone technology. While the product is praised for its convenience and potential, some employer reviews indicate areas for improvement in internal communication and management.

Overall: Mixed

Strengths

  • Innovative use of smartphone technology for cardiac monitoring
  • Convenient and accessible for users
  • Potential for early detection of cardiac issues
  • Positive impact on patient engagement with health
  • Good work-life balance reported by some employees
  • Focus on meaningful healthcare technology

Limitations

  • Accuracy concerns raised by some users (though often clarified as not a medical device)
  • Limited information on specific employer reviews from major platforms like Glassdoor/G2/Capterra directly for 'Qompium nv'
  • Some employer reviews suggest room for improvement in internal communication
  • Potential for misinterpretation of results by users without medical guidance
  • Reliance on user input for data quality
  • Specific product features might not replace professional medical diagnostics

Based on reviews from: G2, Glassdoor, Capterra, Reddit, Healthcare IT News (general industry context), App Store reviews (for Cardiograph/Qompium Cardiograph)

Last updated: 2026-07-21

Videos

News, demos, and interviews about Qompium nv.

Loading videos...

Videos load interactively. If none appear, search YouTube for Qompium nv →

View all on YouTube

Press & Coverage

Extra Horizon
Qompium announces the spin-off of its Extra Horizon business
Qompium NV has officially demerged its Extra Horizon business, a Medical Backend-as-a-Service (MBaaS) platform, to allow both entities to pursue independent growth strategies. Qompium will now focus on its FibriCheck medical app for arrhythmia detection, while Extra Horizon will cater to other medical software startups.
2022-10
EIT Health
EIT Health backed start-up Qompium raises 9 million euros
Belgian digital health company Qompium, supported by EIT Health, secured an additional 9 million euros in funding to accelerate the growth of its FibriCheck and Extra Horizon business units. This capital injection aims to strengthen Qompium's leading role in the digital transformation of the healthcare sector, which has been accelerated by the COVID-19 pandemic.
2021-02
FibriCheck
9 million euros in funding for eHealth pioneer Qompium - FibriCheck
Qompium, a Belgian digital health pioneer, successfully completed a new capital round, raising 9 million euros to further develop its FibriCheck medical app and Extra Horizon platform. The funding will support the company's international ambitions and continued growth in the digital health market.
2021-02
FibriCheck (Dutch)
Digitale gezondheidspionier Qompium haalt 9 miljoen euro op
Qompium, de Belgische pionier in digitale gezondheidszorg, heeft 9 miljoen euro opgehaald in een nieuwe kapitaalronde om de groei van FibriCheck en Extra Horizon te versnellen. De investering zal Qompium in staat stellen een leidende rol te spelen in de digitale transitie van de gezondheidszorg, die door Covid-19 in een stroomversnelling is geraakt.
2021-02
FibriCheck (Dutch)
Qompium kondigt spin-off Extra Horizon aan
Qompium nv heeft de afsplitsing van haar dochteronderneming Extra Horizon, een Medical Backend-as-a-Service (MBaaS) platform, aangekondigd. Deze strategische zet stelt beide organisaties in staat om hun eigen groeipad te volgen, waarbij Qompium zich richt op FibriCheck en Extra Horizon op medische software startups.
2022-10

Frequently Asked Questions

Qompium nv's primary digital health solution is FibriCheck, a medically certified application designed for the detection and monitoring of heart rhythm disorders, particularly atrial fibrillation (AF). This solution comprises a patient-facing mobile app, a validated AI algorithm for analysis, and a dedicated portal for healthcare professionals.
FibriCheck detects heart rhythm disorders by utilizing photoplethysmography (PPG) technology, where patients place a finger on their smartphone camera or use compatible smartwatch sensors for a 60-second measurement. An advanced AI-based algorithm then analyzes the collected PPG data to identify irregular heart rhythms, including atrial fibrillation, with high accuracy.
FibriCheck is a fully medically certified Software as a Medical Device (SaMD), holding both CE Class IIa marking in Europe and FDA clearance (K232804) in the U.S. This regulatory standing ensures its compliance with stringent medical device standards for safety and effectiveness.
FibriCheck facilitates remote patient monitoring by allowing individuals to perform heart rhythm measurements conveniently at home using their personal smartphones. The results are automatically transmitted to a secure healthcare provider portal, enabling clinicians to remotely review patient data, track trends, and make informed clinical decisions without the need for frequent in-person visits.
Qompium nv provides healthcare providers with a dedicated online portal for managing patient cohorts, reviewing aggregated results, and integrating FibriCheck data into existing Electronic Medical Records (EMR) and clinical workflows. Comprehensive support is available through various channels, including email ([email protected]), phone (+32 11 48 59 53), and a live chat feature.
Qompium nv, through FibriCheck, has established partnerships with major technology companies like Samsung and Fitbit, integrating its heart rhythm monitoring capabilities into consumer wearables. The company also collaborates with hospitals and healthcare providers, such as those in the TeleCheck-AF project, to implement digital care pathways and expand its reach, serving over 1.2 million users globally.
FibriCheck offers flexible pricing models, including annual licenses for private practices or hospitals, activation codes for patients (e.g., u20ac10 for 7 days), and direct patient subscriptions. In the U.S., FibriCheck is covered by many commercial insurance providers and Medicare, and certain European health insurance providers also offer reimbursement. The solution is designed for seamless integration into existing clinical workflows and EMR systems, providing structured, actionable data to healthcare providers.

Related Companies

e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]

PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]

Healthcare Finance.AI is a company dedicated to leveraging cutting-edge artificial intelligence to optimize healthcare revenue cycles. Their goal is to improve financial outcomes for healthcare providers while simultaneously supporting the industry’s commitment to quality care and efficiency. They aim to achieve this by enhancing healthcare finance through AI innovation, demonstrating increased revenue cycle efficiency, reducing […]

The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]

Imperial College Business School is a global business school that is part of Imperial College London, a top-ranking science-based institution. Established in 2004, the school integrates business and entrepreneurship with technology. Its roots in business education trace back to 1955 with an operational research/management science course. The school is triple-crown accredited (AACSB, AMBA, EQUIS), placing […]

Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.